The importance of proliferative activity and angiogenesis in meningioma and glioma

Turkish Neurosurgery

Volumn 15, Issue 4, 2005, Pages 176-181

  Atik, Esin ^a   Serarslan, Yurdal ^a   Bakariş, Sevgi ^b   Savaş, Nazan ^a  

^a MUSTAFA KEMAL UNIVERSITY   (Turkey)

^b KAHRAMANMARAS SUTCU IMAM UNIVERSITY   (Turkey)

Author keywords

Angiogenesis; Glioma; Meningioma; Proliferative activity

Indexed keywords

BIOLOGICAL MARKER; CD34 ANTIGEN; KI 67 ANTIGEN;

ADULT; ANGIOGENESIS; ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; CANCER GRADING; CELL PROLIFERATION; DISEASE CLASSIFICATION; DISEASE MARKER; FEMALE; GLIOMA; HISTOLOGY; HUMAN; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; MENINGIOMA; RATING SCALE; STATISTICAL ANALYSIS; TUMOR GROWTH;

EID: 33846669834     PISSN: 10195149     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Abdulrauf SI, Edvardsen K, Ho KL, Yang XY, Rock JP, Rosenblum ML: Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytoma. J Neurosurgery 88: 513-520, 1998
2. Fisher B, Naumova E, Leighton CC, Naumov GN, Kerklviet N, Fortin D, Macdonald DR, Cairncross JG, Bauman GS, Stitt L: Ki-67 A prognostic factor for low grade glioma. Int J. Radiation Oncology Biol. Phys. 52: 996-1001, 2002
3. Horiguchi H, Hirose T, Sano T, Nagahiro S: Loss of chromosome 10 in glioblastoma: Relation to proliferation and angiogenesis. Pathology International 49: 681-686, 1999
4. Karamitopoulou E, Perentes E, Melachrinou M, Maraziotis T: Proliferating cell nuclear antigen immunoreactivity in human central nervous system neoplasm. Acta Neuropathol 85: 316-322, 1993
5. Kayaselcuk F, Zorludemir S, Gümürrdülü D, Zeren H, Erman T: PCNA and Ki-67 in central nervous system tumors: Correlation with the histological type and grade. Journal of Neurooncology 57: 115-120, 2002
6. Korshunov A, Golanov A, Sycheva R: Immunohistochemical markers for prognosis of anaplastic astrocytomas. J Neurooncology 58: 203-215, 2002
7. Lamszus K, Lengler U, Schmidt NO, Stavrou D, Ergun S, Westphal M: Vascular endothelial growth factor, hepatocyte growth factor/ scatter factor, basic fibroblast growth factor in human meningiomas and their relation angiogenesis and malignancy Neurosurgery 46: 938-948, 2000
8. Montine TJ, Vandersteenhoven J, Aguzzi A, Boyko O, Dodge R, Kerns B, Burger P: prognostic significance of Ki-67 proliferation index in supratentorial fibrillary astrocytic neoplasms. Neurosurgery 34: 674-679, 1994
9. Oehring RD, Miletic M, Valter MM, Pietsch T, Neumann J, Fimmers R, Schlegel U: Vascular endothelial growth factor (VEGF) in astrocytic gliomas- a prognostic factor. Journal of Neurooncology 45(2): 117-125, 1999
10. Roggendorf W, Schuster T, Peiffer J: Proliferative potential of meningiomas determined with the monoclonal antibody Ki-67. Acta Neuropathol 73: 361-364, 1987
11. Sen O, Kayaselcuk F, Zorludemir S, Aydin MV, Erdoǧan B: Correlation of Flowcytometric DNA analysis, PCNA and Ki-67 in Histopathological Diagnosis of meningioma. Turkish Journal of Neurosurgery 12: 48-53, 2002
12. Torp SH, Alsaker M: Ki-67 Immunoreactivity, basic fibroblastic growth factor (bFGF) expression, and microvessel density as supplementary prognostic tools in low-grade astrocytomas. Pathology Research and practice 198: 261-265, 2002
13. Tihan T, Davis R, Elowitz E, DiCostanzo D, Moll U: Practical value of Ki-67 and p53 labeling indexes in stereotactic biopsies of diffuse and pilocytic astrocytomas Archives of Pathology and Laboratory Medicine 124: 108-114, 2000
14. Vaquero JU, Zurita M, Morales C, Oya S, Coca S: Prognostic significance of endothelial surface score and MIB-1 labeling index in glioblastoma. J Neurooncology 46: 11-16, 2000
15. Vaquero J, Zurita M, Coca S, Oya S, Morales C: Prognostic significance of clinical and angiogenesis-related factors in low grade oligodenrogliomas. Surg Neurol 54: 229-234, 2000